[Linton MF, Farese RV Jr, Young SG. Familial hypobetalipoproteinemia. J Lipid Res. 1993; 34(4): 521-541.10.1016/S0022-2275(20)39976-4]Search in Google Scholar
[Tarugi P, Averna M, Di Leo E, Cefalu AB, Noto D, Magnolo L, Cattin L, Bertolini S, Calandra S. (Author: all authors must be cited) Molecular diagnosis of hypobetalipoproteinemia: an ENID review. Atherosclerosis. 2007; 195(2): e19-27.10.1016/j.atherosclerosis.2007.05.00317570373]Search in Google Scholar
[Burnett JR, Hooper AJ. Common and rare gene variants affecting plasma LDL cholesterol. Clin Biochem Rev. 2008; 29(1): 11-26.]Search in Google Scholar
[Whitfield AJ, Barrett PH, van Bockxmeer FM, Burnett JR. Lipid disorders and mutations in the APOB gene. Clin Chem. 2004; 50(10): 1725-1732.10.1373/clinchem.2004.03802615308601]Search in Google Scholar
[Olofsson SO, Wiklund O, Boren J. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag. 2007; 3(4): 491-502.]Search in Google Scholar
[Schonfeld G. Familial hypobetalipoproteinemia: a review. J Lipid Res. 2003; 44(5): 878-883.10.1194/jlr.R300002-JLR20012639976]Search in Google Scholar
[Schonfeld G, Lin X, Yue P. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol Life Sci. 2005; 62(12): 1372-1378.10.1007/s00018-005-4473-015818469]Search in Google Scholar
[Elias N, Patterson BW, Schonfeld G. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 1999; 19(11): 2714-2721.10.1161/01.ATV.19.11.2714]Search in Google Scholar
[Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci. 2005; 42(5-6): 515-545.10.1080/1040836050029511316390683]Search in Google Scholar
[Amaro A, Fabbrini E, Kars M, Yue P, Schechtman K, Schonfeld G, Klein S. (Author: all authors must be cited) Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology. 2010; [Epub ahead of print].10.1053/j.gastro.2010.03.039290271420303351]Search in Google Scholar
[Sankatsing R, Fouchier S, de Haan S, Hutten B, de Groot E, Kastelein J, Stroes ES. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 2005; 25(9): 1979-1984.10.1161/01.ATV.0000176191.64314.0716002743]Search in Google Scholar
[Cohen J, Boerwinkle E, Mosley TJ, Hobbs H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354(12): 1264-1272.10.1056/NEJMoa05401316554528]Search in Google Scholar
[Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Arbor: Cold Spring Laboratory; 1989.]Search in Google Scholar
[Knott T, Wallis S, Powell L, Pease R, Lusis A, Blackhart B, McCarthy BJ, Mahley RW, Levy-Wilson B, Scott J. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res. 1986; 14(18): 7501-7503.10.1093/nar/14.18.7501]Search in Google Scholar
[Tarugi P, Lonardo A, Ballarini G, Erspamer L, Tondelli E, Bertolini S, Calandra S. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5). J Hepatol. 2000; 33(3): 361-370.10.1016/S0168-8278(00)80270-6]Search in Google Scholar
[Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res. 2004; 45(5): 941-947.10.1194/jlr.M300508-JLR200]Search in Google Scholar
[Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol. 2006; 47(6): 1093-1100.10.1016/j.jacc.2005.11.046]Search in Google Scholar
[Alberti KG, Zimmet P, Shaw J. The metabolic syndrome — a new worldwide definition. Lancet. 2005; 366(9491): 1059-1062.10.1016/S0140-6736(05)67402-8]Search in Google Scholar
[Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-2497.10.1001/jama.285.19.248611368702]Search in Google Scholar